Hot Blue Chip Stocks To Watch For 2021

Egg Harbor Township, NJ, based Investment company Hanlon Investment Management, Inc. buys SPDR Bloomberg Barclays High Yield Bond, iShares iBoxx $ High Yield Corporate Bond, SPDR MidCap Trust Series I, SPDR S&P 600 Small Cap ETF (based on S&P SmallCap , SPDR Bloomberg Barclays Short Term High Yield Bond, PIMCO 0-5 Year High Yield Corporat Bond Index Exch, sells SPDR Select Sector Fund – Financial, PowerShares Emerging Markets Sovereign Debt Portfo, SPDR Bloomberg Barclays Convertible Securities, SPDR Select Sector Fund – Technology, SPDR Select Sector Fund – Health Care during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Hanlon Investment Management, Inc.. As of 2017-09-30, Hanlon Investment Management, Inc. owns 16 stocks with a total value of $37 million. These are the details of the buys and sells.

New Purchases: JNK, MDY, SLY, SJNK, HYS, Added Positions: HYG, Reduced Positions: XLF, CWB, XLK, XLV, XLY, XLI, XLP, XLU, XLRE, XLB, Sold Out: PCY, SPY, QQQ, VNQ, IWO, IJK, VWO, IJJ, VEA, IWN,

For the details of Hanlon Investment Management, Inc.’s stock buys and sells, go to

Hot Blue Chip Stocks To Watch For 2021: DigitalGlobe, Inc(DGI)

DigitalGlobe is a leading global provider of high-resolution Earth-imagery products and services sourced from our own advanced satellite constellation and third-party providers. Our imagery solutions support a wide variety of users in defense and intelligence, civil agencies, mapping and analysis, environmental monitoring, oil and gas exploration, infrastructure management, Internet portals, and navigation technology. Each day users depend on us to better understand our changing planet in order to save lives, resources and time.

We were originally incorporated as EarthWatch on September 30, 1993 under the laws of the State of Colorado and reincorporated in the State of Delaware on August 21, 1995. On August 22, 2002, we changed our name to DigitalGlobe, Inc. Our common stock has been listed on the New York Stock Exchange (“NYSE”) and traded under the symbol “DGI” since our initial public offering in May 2009.   Advisors’ Opinion:

Hot Blue Chip Stocks To Watch For 2021: Optical Cable Corporation(OCC)

Optical Cable Corporation, together with its subsidiaries, manufactures and sells fiber optic and copper data communications cabling and connectivity solutions for the enterprise market in the United States and internationally. The company provides fiber optic cables for high bandwidth transmission of data, video, and voice communications; and copper datacom cables, including unshielded and shielded twisted pair. It also offers fiber optic connectivity products, including fiber optic wall mounts, cabinet mount and rack mount enclosures, pre-terminated fiber optic enclosures, fiber optic connectors, splice trays, fiber optic jumpers, plug and play cassette modules, pre-terminated fiber optic cable assemblies, adapters, and accessories. In addition, the company provides copper connectivity products comprising category compliant patch panels, jacks, plugs, patch cords, faceplates, surface mounted boxes, distribution and multi-media boxes, copper rack mount and wall mount enclosures, cable assemblies, cable organizers, and other wiring products for datacenter, telecommunications closet, equipment room, and workstation applications. Further, it offers network, data storage, and telecommunications management systems, such as data cabinets, wall-mount enclosures, cable management systems, and open frame relay racks for commercial and residential use; and datacom wiring products, such as various enclosures, modules, and modular outlets for single dwelling and multiple dwelling residential uses. Additionally, the company provides applied interconnect systems, which include specialty fiber optic connectors and connectivity components, ruggedized copper datacom connectors, and related systems and solutions for military and harsh environment applications. It sells its products to distributors, original equipment manufacturers, value-added resellers, and end-users. Optical Cable Corporation was founded in 1983 and is headquartered in Roanoke, Virginia.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Octoin Coin (CURRENCY:OCC) traded down 0.1% against the dollar during the 24 hour period ending at 17:00 PM ET on September 18th. One Octoin Coin coin can currently be bought for approximately $0.20 or 0.00003171 BTC on exchanges including Exrates and YoBit. Octoin Coin has a market cap of $81,668.00 and approximately $961,535.00 worth of Octoin Coin was traded on exchanges in the last day. In the last seven days, Octoin Coin has traded 0.3% higher against the dollar.

  • [By Shane Hupp]

    Media coverage about Optical Cable (NASDAQ:OCC) has trended positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Optical Cable earned a coverage optimism score of 0.31 on Accern’s scale. Accern also gave news stories about the communications equipment provider an impact score of 46.3231627277527 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Octoin Coin (CURRENCY:OCC) traded up 7% against the US dollar during the 24-hour period ending at 8:00 AM ET on June 28th. One Octoin Coin coin can currently be purchased for $0.32 or 0.00005167 BTC on exchanges including Exrates and YoBit. During the last week, Octoin Coin has traded 17% lower against the US dollar. Octoin Coin has a market capitalization of $131,298.00 and $1.10 million worth of Octoin Coin was traded on exchanges in the last 24 hours.

  • [By Stephan Byrd]

    Optical Cable Co. (NASDAQ:OCC) Chairman Neil D. Wilkin, Jr. sold 10,000 shares of Optical Cable stock in a transaction on Tuesday, June 19th. The stock was sold at an average price of $3.50, for a total transaction of $35,000.00. Following the transaction, the chairman now directly owns 1,074,405 shares in the company, valued at $3,760,417.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Hot Blue Chip Stocks To Watch For 2021: Vanda Pharmaceuticals Inc.(VNDA)

Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system (CNS) disorders. The Company’s product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostatin A and AQW051.


The Company offers HETLIOZ (tasimelteon) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is a melatonin agonist of the human MT1 and MT2 receptors, with specificity for MT2. HETLIOZ has utility in a range of circadian rhythm disorders, and is in in clinical development for the treatment of Jet Lag Disorder and Smith-Magenis Syndrome (SMS).


The Company offers Fanapt (iloperidone) for the treatment of schizophrenia. Additionally, its distribution partners launched Fanapt in Israel and Mexico.


Tradipitant (VLY-686) is a small molecule neurokinin-1 receptor (NK-1R) antagonist, which is in clinical development for the treatment of chronic pruritus in atopic dermatitis. NK-1R antagonists have been evaluated in a range of indications, including chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), alcohol dependence, anxiety, depression and pruritus.

Trichostatin A

Trichostatin A is a small molecule histone deacetylase (HDAC) inhibitor. It has a potential use as a treatment for several oncology indications.


AQW051 is a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. It is indicated for the treatment of CNS Disorders.

The Company competes with Takeda Pharmaceuticals Company Limited, Sanofi, Sunovion Pharmaceuticals Inc., Pfizer Inc., Pernix Therapeutics, Merck & Co., Inc., Servier, Neurim Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ortho-McNeil-Janssen Pharmaceuticals, In! c., Eli Lilly and Company, AstraZeneca PLC, BMS/Otsuka America Pharmaceutical Inc., Lundbeck/Otsuka America Pharmaceutical Inc., Actavis plc, Otsuka Pharmaceutical, Inc. and Alkermes, Inc.

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine lowered shares of Vanda Pharmaceuticals (NASDAQ:VNDA) from a buy rating to a hold rating in a report issued on Saturday.

    Several other brokerages have also commented on VNDA. Oppenheimer dropped their price target on shares of Vanda Pharmaceuticals from $29.00 to $21.00 in a research report on Thursday, February 14th. Jefferies Financial Group upped their price target on shares of Vanda Pharmaceuticals from $30.00 to $40.00 and gave the stock a buy rating in a research report on Tuesday, December 4th. Cantor Fitzgerald raised shares of Vanda Pharmaceuticals from a neutral rating to an overweight rating and set a $43.00 price target for the company in a research report on Tuesday, December 4th. Citigroup upped their price target on shares of Vanda Pharmaceuticals from $31.00 to $47.00 and gave the stock a buy rating in a research report on Friday, December 7th. Finally, CIBC reaffirmed a market perform rating on shares of Vanda Pharmaceuticals in a research report on Tuesday, December 11th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of Hold and an average target price of $34.75.

  • [By Joseph Griffin]

    Vanda Pharmaceuticals (NASDAQ:VNDA) last posted its quarterly earnings data on Wednesday, February 13th. The biopharmaceutical company reported $0.19 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.22. Vanda Pharmaceuticals had a return on equity of 9.80% and a net margin of 13.05%. The business had revenue of $53.04 million for the quarter, compared to the consensus estimate of $51.56 million. During the same quarter in the prior year, the business earned ($0.04) earnings per share. Vanda Pharmaceuticals’s revenue for the quarter was up 19.8% on a year-over-year basis. Equities analysts anticipate that Vanda Pharmaceuticals Inc. will post 0.22 earnings per share for the current year.

  • [By Maxx Chatsko]

    Shares of lithium producer Livent (NYSE:LTHM) and newly profitable Vanda Pharmaceuticals (NASDAQ:VNDA) have underperformed the broader stock market in recent months. The former has been handicapped by the fact that its parent company, FMC, owned 84% of outstanding shares long after it went public. That significantly limited its financial flexibility and ability to court large institutional investors. The latter announced it’s suing the U.S. Food and Drug Administration because, you know, that always works.

Hot Blue Chip Stocks To Watch For 2021: RAIT Financial Trust(RAS)

We are a multi-strategy commercial real estate company that is a self-managed and self-advised Maryland real estate investment trust, or REIT. We utilize our vertically integrated platform to originate commercial real estate loans, acquire commercial real estate properties and invest in, manage and service commercial real estate assets. We offer a comprehensive set of debt financing options to the commercial real estate industry and provide asset and property management services. We also own and manage a portfolio of commercial real estate properties and manage real estate assets for third parties. We were formed in August 1997 and commenced operations in January 1998.   Advisors’ Opinion:

  • [By Stephan Byrd]

    RAIT Financial Trust (NYSE:RAS) will announce its earnings results before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.21 per share for the quarter.

Hot Blue Chip Stocks To Watch For 2021: LivePerson Inc.(LPSN)

LivePerson, Inc. provides online engagement solutions that facilitate real-time assistance and expert advice in the United States, Canada, Latin America, Europe, and the Asia-Pacific region. The company facilitates real-time online interactions, such as chat, voice/click-to-call, email, and self-service/knowledgebase for corporations of various sizes; and connects businesses and independent service providers with individual consumers seeking help on its hosted software platform. Its products and services comprise LP Chat that creates real-time connections for businesses to connect with consumers through Websites, social media, and mobile devices; LP Voice, which provides customers a connection between a Website and the voice channel to engage prospects and consumers online; and LivePerson Expert Platform, a marketplace platform that allows users to chat live with independent experts in various categories. The company?s products and services also include LP Marketer that o ffers a real-time data-driven targeting solution that delivers personalized digital user experiences; and LP Insights, which provide customers with a text analytics tool that enables them to data mine for ?Voice of the Customer? and ?Voice of the Agent? content. In addition, it offers provides professional services and value-added business consulting services. The company sells its products through direct and indirect sales channels to small and mid-sized businesses, Internet businesses, online merchants, universities, libraries, government agencies, and not-for-profit organizations, as well as to financial, retail, telecommunications, technology, and travel/hospitality industries. LivePerson, Inc. was founded in 1995 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Matthew Frankel, CFP]

    In the latest installment of our Between Two Fools interview series, Industry Focus: Financials host Jason Moser sits down with LivePerson (NASDAQ:LPSN) CEO Rob LoCascio.

  • [By ]

    Sitting right in the middle of this esteemed group, LivePerson (Nasdaq: LPSN), a technology company transforming the way customers communicate with brands (and vice versa), is trading not only near its 52-week high but also near its all-time highs. And since I added the stock to our Game-Changing Stocks portfolio on December 21, and we’re already up more than 60%.

  • [By Keith Noonan]

    LivePerson (NASDAQ:LPSN) stock gained 19.1% in February, according to data from S&P Global Market Intelligence. The online customer service company’s shares saw positive momentum early in the month thanks to bullish trends for the broader market, and gains accelerated following its fourth-quarter earnings release and some encouraging guidance.

  • [By Stephan Byrd]

    In other LivePerson news, CEO Robert P. Locascio sold 45,837 shares of LivePerson stock in a transaction dated Thursday, January 3rd. The stock was sold at an average price of $18.06, for a total value of $827,816.22. Following the completion of the transaction, the chief executive officer now directly owns 266,997 shares of the company’s stock, valued at approximately $4,821,965.82. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Locascio sold 3,405 shares of LivePerson stock in a transaction dated Wednesday, December 19th. The shares were sold at an average price of $18.82, for a total value of $64,082.10. Following the completion of the transaction, the chief executive officer now directly owns 312,834 shares of the company’s stock, valued at $5,887,535.88. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 52,472 shares of company stock valued at $953,572. 11.50% of the stock is currently owned by corporate insiders.

    COPYRIGHT VIOLATION NOTICE: “LivePerson, Inc. (LPSN) Stake Lessened by Castleark Management LLC” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at

    LivePerson Company Profile

Leave a Reply

Your email address will not be published. Required fields are marked *